Investment
Features
FeesSafety
Academy
More
Pluang+

Compare TG Therapeutics Inc (TGTX) vs Twist Bioscience Corp (TWST) Price & Performance

TG Therapeutics IncTrade
Twist Bioscience CorpTrade

Price performance (Past 24H)

Key statistics

TG Therapeutics Inc vs Twist Bioscience Corp — how do they compare? TG Therapeutics Inc trades at $54.06 (market cap $8.26B), while Twist Bioscience Corp trades at $88.31 (market cap $5.45B). The key difference: TG Therapeutics Inc is the larger of the two by market cap. Which is the better fit depends on your goals.

TGTXTWST
Market Cap
$8.26B$5.45B
Sector
HealthHealth
52-Week High
$59.06$102.88
52-Week Low
$26.39$24.16
Enterprise Value
$8.50B$5.37B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About TG Therapeutics Inc

TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.

Read more on TGTX

About Twist Bioscience Corp

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.

Read more on TWST